thromboxanes has been researched along with Peripheral Vascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butcher, JT; Chantler, PD; Frisbee, JC; Frisbee, SJ; Goodwill, AG; Wu, F | 1 |
| Eikelboom, JW; Hackam, DG | 1 |
2 review(s) available for thromboxanes and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Microvascular perfusion heterogeneity contributes to peripheral vascular disease in metabolic syndrome.
Topics: Animals; Humans; Metabolic Syndrome; Microcirculation; Muscle, Skeletal; Peripheral Vascular Diseases; Thromboxanes | 2016 |
Antithrombotic treatment for peripheral arterial disease.
Topics: Anticoagulants; Fibrinolytic Agents; Forecasting; Humans; Peripheral Vascular Diseases; Pyridines; Thromboxanes | 2007 |